Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

Date

Lunedì, 5 Febbraio 2024, All day
Giovedì, 8 Febbraio 2024, All day

Sede

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 KB - PDF)

Pubblicato per la prima volta: Ultimo aggiornamento:
Visualizza

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 KB - PDF)

Pubblicato per la prima volta:
Visualizza

Share this page